# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1020661 | F | Antiproliferative activity against human OPM2 cells after 72 hrs by luciferase based assay | Homo sapiens | 2 | ALA1139384 | cell-based format | Scientific Literature | |
2. | ALA1115472 | F | Antiproliferative activity against human OPM2 cells assessed as intracellular ATP level after 72 hrs by luminometry | Homo sapiens | 1 | ALA1157785 | cell-based format | Scientific Literature | |
3. | ALA1249903 | F | Cytotoxicity against human OPM2 cells after 72 hrs by alamar blue assay | Homo sapiens | 2 | ALA1240297 | cell-based format | Scientific Literature | |
4. | ALA2015393 | F | Cytotoxicity against human OPM2 cells after 96 hrs by trypan blue exclusion assay | Homo sapiens | 2 | ALA2010670 | cell-based format | Scientific Literature | |
5. | ALA2039840 | F | Cytotoxicity against human OPM2 cells after 48 hrs by luminometric analysis | Homo sapiens | 5 | ALA2034906 | cell-based format | Scientific Literature | |
6. | ALA2039854 | F | Cytotoxicity against human OPM2 cells after 48 hrs by luminometric analysis in presence of HS5 bone marrow stromal cells | Homo sapiens | 5 | ALA2034906 | cell-based format | Scientific Literature | |
7. | ALA2184788 | F | Resistance factor, ratio of IC50 for bortezonib-resistant human OPM2 cells harboring proteosome subunit beta5 A49T mutant to IC50 for wild type human OPM2 cells | Homo sapiens | 1 | ALA2176951 | cell-based format | Scientific Literature | |
8. | ALA2363574 | F | SANGER: Inhibition of human OPM-2 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
9. | ALA4023209 | F | Growth inhibition of human OPM2 cells after 72 hrs in presence of 10% FBS by Cell-TiterGlo assay | Homo sapiens | 4 | ALA4020825 | cell-based format | Scientific Literature | |
10. | ALA4031338 | F | Antiproliferative activity against human OPM2 cells after 48 hrs by CellTiter-Glo luminescent assay | Homo sapiens | 5 | ALA4028864 | cell-based format | Scientific Literature | |
11. | ALA4031346 | F | Antiproliferative activity against human OPM2 cells assessed as cell viability at 10 uM after 48 hrs by CellTiter-Glo luminescent assay relative to control | Homo sapiens | 1 | ALA4028864 | cell-based format | Scientific Literature | |
12. | ALA4038390 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 100 mg/kg, po qd for 14 days measured twice per week during compound dosing relative to control | Homo sapiens | 1 | ALA4038268 | organism-based format | Scientific Literature | |
13. | ALA4038398 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 100 mg/kg, po bid for 14 days measured twice per week during compound dosing relative to control | Homo sapiens | 1 | ALA4038268 | organism-based format | Scientific Literature | |
14. | ALA4038399 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 30 mg/kg, po qd for 21 days measured twice per week during compound dosing relative to control | Homo sapiens | 1 | ALA4038268 | organism-based format | Scientific Literature | |
15. | ALA4038400 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 150 mg/kg, po qd for 21 days measured twice per week during compound dosing relative to control | Homo sapiens | 1 | ALA4038268 | organism-based format | Scientific Literature | |
16. | ALA4051126 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 1 mg/kg, po qd for 21 days relative to control | Homo sapiens | 2 | ALA4049425 | organism-based format | Scientific Literature | |
17. | ALA4051127 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 3 mg/kg, po qd for 21 days relative to control | Homo sapiens | 1 | ALA4049425 | organism-based format | Scientific Literature | |
18. | ALA4051130 | F | Antiproliferative activity against human OPM2 cells | Homo sapiens | 2 | ALA4049425 | cell-based format | Scientific Literature | |
19. | ALA4051134 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition at 1 to 3 mg/kg, po qd measured after 21 days | Homo sapiens | 1 | ALA4049425 | organism-based format | Scientific Literature | |
20. | ALA4051136 | F | Antitumor activity against human OPM2 cells xenografted in SCID-Beige mouse assessed as tumor growth inhibition compound administered po qd for 21 days | Homo sapiens | 1 | ALA4049425 | organism-based format | Scientific Literature |